Introduction
Changes in peripheral thyroid hormone concentration and metabolism can occur in euthyroid patients suffering from severe non-thyroidal illnesses' 1 " 4 '. The most frequent finding in these patients is a decrease in serum total triiodothyronine concentration, sometimes to extremely low levels, accompanied by an increase in the Revision submitted 19 February 1996 . and accepted 26 February 1996 .
Correspondence: Cristina Opasich, Divisione di Cardiologia. Centro Medico di Montescano. 27040 Montescano (PV). Italy. serum concentration of reverse triiodothyronine. These changes have mainly been ascribed to a reduction in the 5'-monodeiodination of quiiodothyronine and reverse triiodothyronine 151 . A marked reduction in total triiodothyronine concentration usually leads to a reduction in free triiodothyronine. Patients with these findings are usually referred to as having the 'sick euthyroid syndrome'. The syndrome is associated both with chronic diseases, such as liver and kidney diseases, starvation, neoplasms and diabetes, and with acute illnesses, such as myocardial infarction, severe systemic infections and trauma' 6 " 8 '. Recently, sick euthyroid syndrome has been reported in patients suffering from advanced heart failure! 910 '. To gain insight into the prevalence and the pathophysiological implications of sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure, we prospectively investigated thyroid function in patients consecutively admitted to our heart failure unit for assessment for cardiac transplantation.
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Methods
Patients
This study involved 199 out of the 304 patients admitted to our heart failure unit between March 1992 and April 1994. One hundred and five patients were excluded because of the use of amiodarone, beta-blockers, steroids and the presence of clinical or historical evidence of thyroid disorders. All patients were admitted for assessment for cardiac transplantation. The clinical characteristics of the patients enrolled are shown in Table 1 . Eighty-six percent of them were male. Heart failure was due to ischaemic heart disease in 44% of the cases, and to dilated cardiomyopathy in another 38%. All patients had suffered at least one episode of severe cardiac decompensation. At enrolment, 46% of the patients were in NYHA class III or IV 1 " 1 . Treatment was with ACE inhibitors, vasodilators (nitroprusside, isosorbide dinitrate, hydralazine), digoxin, diuretics, monoglycoside inotropic drugs (dopamine, dobutamine, enoximone) when needed, and, in the absence of contraindications, with anticoagulants (INR 2-2-5). All the patients were closely followed-up with clinical and instrumental examinations. The average follow-up was 417 ± 259 days (mean ± SD) (median 369 days); all patients were observed for at least 6 months.
Measurements
When patients were clinically stabilized, we performed an exhaustive evaluation of the following.
Blood determination
Serum thyroid hormones (free triiodothyronine, free quiiodothyronine, total quiiodothyronine and total triiodothyronine) and thyroid-stimulating hormone were measured by radioimmunology (SPAC total triiodothyronine and SPAC total quiiodothyronine, RIA-coat free triiodothyronine and RIA-coat free quiiodothyronine, IRMA-mat thyroid stimulating hormone, Byk Gulden, Cormano, Italy); plasma norepinephrine was measured with high performance liquid chromatography and electromechanical detection' 1213 '; atrial natriuretic factor was measured by radioimmunoassay (Elken Immunochemical, Tokyo, Japan), preceded by solid-phase extraction (Sep-Pak C-18 Cartridges, Waters/Millipore, Milford, MA, U.S.A.) as previously described'
141
. Renin and aldosterone were measured with radioimmunoassay; plasma cortisol and insulin levels were measured by radioimmunology (CORD-CT radioimmunoassay Kit, CIS France; COAT A Count Insulin-D.P.C, LA, California, U.S.A.); other measurements included plasma bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), cholinesterase, alkaline phosphatase, gammaglutamyltranspeptidase (GGT), albumin, creatinine, sodium and magnesium
Nutritional evaluation
Percent actual/ideal body weight was calculated from the division of actual by ideal body weight, as estimated from standard tables' 151 . Malnutrition was defined as less than 90% of the ideal body weight.
Cardiac function evaluation
Right heart catheterization was carried out in 177 patients, and a cardiopulmonary exercise test in 178 patients (all the other patients had a clinical cardiac contraindication to the test); 24 h dynamic ECG monitoring was performed to detect conduction disorders, significant ventricular ectopic beats (more than 10 per hour) and significant ventricular tachycardia (more than 10 beats).
Definition of sick euthyroid syndrome
We defined sick euthyroid syndrome as the cooccurrence of a serum total triiodothyronine value of less than the lowest laboratory normal limit (1-23 nmol. 1~') with a normal serum thyroid stimulating hormone, concentration (normal values: 0-1-
Statistical analysis
Significant differences between sick euthyroid syndrome and non-sick euthyroid syndrome patients were Eur Heart J, Vol. 17, December 1996 
Results
We found low serum total triiodothyronine concentrations (< 1 -23 nmol . 1 ~ ') in 36 patients (sick euthyroid syndrome group) (18%). Mean total triiodothyronine values were 0-9 ± 003 nmol. 1" ' (range: 0-53 ± 118 nmol. 1~ '). Although total quiiodothyronine and free quiiodothyronine were in the normal range in all patients, as shown in Table 2 , sick euthyroid syndrome patients had mean total quiiodothyronine, free quiiodothyronine and free triiodothyronine values that were significantly lower than those of non-sick euthyroid syndrome patients, while mean serum thyroid stimulating hormone values did not differ between the two groups. In all patients, total triiodothyronine was significantly correlated to free quiiodothyronine (r=0-39; F<0001) and total quiiodothyronine (r=0-42; / > <0001). No significant relationship was found between total triiodothyronine and free triiodothyronine values, although 26 sick euthyroid syndrome patients also showed free triiodothyronine levels below the normal range, and six patients had low free triiodothyronine with normal total triiodothyronine values (Fig. 1) .
When we analysed the clinical, haemodynamic and functional features of sick euthyroid syndrome patients (Table 3) , we found that they corresponded to the more severe NYHA classes (31% of NYHA class III-IV, vs 7% of NYHA class I and II, /><0001). Body weight and ideal body weight% were lower for sick euthyroid syndrome patients, six of whom (19%) vs 11 (7%) non-sick euthyroid syndrome patients were malnourished. No significant difference was found for duration of the disease, underlying heart disease, frequency of conduction defects and tachyarrhythmias. Cardiac function was markedly different between the two groups. Cardiac index and filling pressures were more significantly altered in sick euthyroid syndrome patients. Moreover, sick euthyroid syndrome patients had greater cardiovascular functional impairment, as assessed by a lower VO 2 peak. In comparison with non-sick euthyroid syndrome patients, several liver function parameters in those with sick euthyroid syndrome were significantly altered (Table 4) . Among the non-thyroid hormones assessed, serum norepinephrine and atrial natriuretic factor were significantly increased and insulin was reduced in those with sick euthyroid syndrome compared to non-sick euthyroid syndrome patients (Table 4) . Total triiodothyronine was strongly correlated only with albumin (r=0-50; /><00001) and with cholinesterase (r=0-62; / ) <00001). Nine patients in the sick euthyroid syndrome group and 22 in the non-sick euthyroid syndrome group underwent cardiac transplantation. Of the other 168 patients who were not transplanted, 43 (25%) suffered cardiac death. As shown in Table 5 , deaths were significantly more frequent in sick euthyroid syndrome patients (13/27, 48%) than in non-sick euthyroid syndrome (30/141, 21%; / ) <0005). Furthermore, deaths within 6 months of admission to our heart failure unit were more frequent in the sick euthyroid syndrome group (11/27, 41% vs 15/141, 11%; / > <0001). Univariate analysis, including both haemodynamic and humoral variables, showed that pulmonary wedge pressure, cardiac index, sodium, albumin, cholinesterase, AST, yGT, alkaline, phosphatase, bilirubin, norepinephrine and total triiodothyronine were significantly (/ > <005) altered in patients who died in comparison to those who survived. In a stepwise logistic multivariate analysis, only pulmonary capillary wedge pressure and yGT proved to be independent predictors of mortality (/ > <005). However, when we only consider the routine haematological variables (albumin, cholinesterase, alkaline phosphatase, AST, ALT, yGT, bilirubin, sodium, magnesium, creatinine), in a multivariate logistic regression, total triiodothyronine and sodium were identified as independent prognostic factors (/><0005). The different impact of total triiodothyronine on the two models considered is probably due to the significant associations between total triiodothyronine and the haemodynamic variables (with pulmonary wedge pressure: r= -0-27, /><0-001; with right atrial pressure: r= -0-26, /><0-001; with cardiac index: r=0-30, /><0001). 
Effect of heart transplantation
Thyroid hormone measurements were available for six of the nine sick euthyroid syndrome patients who underwent cardiac transplantation. As shown in Fig. 2 , total triiodothyronine increased in all of them, and normalized in five. Mean values increased from 09 ± 01 pre-to 1 -96±0-3 nmol. 1"' post-transplant (P<005).
Discussion
Sick euthyroid syndrome is frequently associated with severe acute and chronic systemic diseases' 1 " 10 '. Often, it is correlated with duration and severity of the disease, and with mortality.
The results of this study show that in a large and representative population of moderate-to-severe chronic heart failure patients, the features of sick euthyroid syndrome are prevalent in 18% of the cases. The most common abnormality was a reduction in either total triiodothyronine or free triiodothyronine levels, some patients showing a decrease in both. Moreover, when sick euthyroid syndrome was defined by free triiodothyronine level (value of less than the lowest laboratory normal limit), its prevalence was 16%, and the concordance of the definitions was 92%. Triiodothyronine reduction was more frequent in patients in NYHA classes III and IV.
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Pre heart transplant Post heart transplant Figure 2 Post-heart transplantation total triiodothyronine modifications in six sick euthyroid syndrome patients.
Sick euthyroid syndrome was also associated with a catabolic pattern (low insulin, high cortisol levels) and a poor nutritional status (lower body weight and ideal body weight%, lower albumin levels). Both conditions are known to be associated with alterations in the thyroid hormone metabolism. Triiodothyronine reduction is considered to be a mechanism of adaptation to increased catabolism' 16 ' 17 '. The mechanism that leads to low triiodothyronine syndrome is not fully understood, but a reduction in peripheral conversion of quiiodothyronine to triiodothyronine by type I 5'-deiodinase enzyme is a well recognized alteration' 35 ' 716 " 18 '. Reduction in the enzyme content and activity in hepatocytes, as well as inhibition of the cellular transport of iodothyronines and their subsequent deiodination, are apparently involved in the conversion of quiiodothyronine to triiodothyronine in sick euthyroid syndrome patients. A further factor may be the inhibitory effect of cytokines on thyroidal 5'-deiodinase activity, and hence reduced triiodothyronine production by the thyroid gland'
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. Yet another explanation for a reduction in total triiodothyronine might be a reduction in thyroid binding proteins. In sick euthyroid syndrome patients, albumin levels were low, but albumin-bound triiodothyronine constitutes only 5% of total triiodothyronine' 19 '. Although thyroid binding globulin and thyroid binding prealbumin were not assessed in this study, it is possible that the severe liver impairment found in our patients may have contributed to a reduction in these binding proteins.
One of the most intriguing aspects of sick euthyroid syndrome is whether patients with low total triiodothyronine concentrations are hypothyroid at the peripheral level. Hypothyroidism is known to impair the intrinsic contractile state of the myocardium' 20 ' 21 ', which could contribute to the further worsening of the ventricular function. This study was not designed to test this hypothesis. We can only observe that the ventricular function in sick euthyroid syndrome patients was much more severely impaired than in non-sick euthyroid syndrome patients.
Hypothyroidism may be arrhythmogenic by prolonging the ventricular refractory period and by dispersing refractoriness' 2223 '. In our population, conduction defects and non-sustained ventricular tachycardia were more frequent in sick euthyroid syndrome patients, although not significantly. Hypothyroidism has been associated with a reduction in atrial natriuretic factor' 241 , a cardiac hormone that counteracts fluid retention in heart failure; but in our series, atrial natriuretic factor was found to be increased. It is likely that the mechanisms which enhance atrial natriuretic factor release, secondary to heart failure, overcome those which primarily regulate atrial natriuretic factor concentration through thyroid hormone.
Total triiodothyronine reduction may present a prognostic hallmark. However, in a multivariate analysis which was comprehensive of all invasive and noninvasive univariate predictors of mortality, only pulmonary wedge pressure and yGT proved to be significant independent prognostic indicators. This result is probably due to the strict association between total triiodothyronine and the haemodynamic pattern, but is at variance with Hamilton's study' 91 , in which thyroid hormone was the strongest predictor of short-term outcome in a multivariate analysis that took the haemodynamic parameters into account. The reason for this discrepancy is most probably the method that Hamilton et al. used to select sick euthyroid syndrome patients. The researchers selected an arbitrary cut-off based on the ratio free triiodothyronine index/reverse triiodothyronine to divide sick euthyroid syndrome and non-sick euthyroid syndrome patients. Thus, from our study it seems that sick euthyroid syndrome is simply a marker of the severity of chronic heart failure. The clinical implications of these results differ from those of Hamilton' 91 .
However, when applying multivariate logistic regression to total triiodothyronine and the other haematological variables which are routinely measured in chronic heart failure, we found that total triiodothyronine and sodium were independent prognostic indicators. This result suggests that total triiodothyronine determination may be included in the routine noninvasive assessment of chronic heart failure, as being an easy-to-determine marker of severity.
As in other chronic diseases, reversion of the underlying condition is associated with sick euthyroid syndrome reversibility, as shown by the increase in serum thyroid hormones observed after cardiac transplantation.
Moreover, it is possible that the correction of sick euthyroid syndrome offers therapeutic advantages: some authors' 25 ' 26 ' reported promising results in cardiac and exercise performance in chronic heart failure patients after short-term administration of a thyroid hormone analogue.
In conclusion, from our study sick euthyroid syndrome was shown to be prevalent in 18% of patients with moderate-to-severe chronic heart failure, and while the occurrence of sick euthyroid syndrome was not related to the aetiology of chronic heart failure, it was related to the degree of functional cardiac impairment. Sick euthyroid syndrome was not an independent negative prognostic factor; it seems simply to be a marker of severity. Preliminary results indicate that heart transplantation is associated with reversal of sick euthyroid syndrome.
